Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| SRC | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 345.0 | Evidence | |||||
| SRC | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
| SRC | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 275.0 | Evidence |
|
||||
| SRC | CRKL | CRKL: Crk-like protein | 275.0 | Evidence | |||||
| SRC | NCK2 | NCK2: Cytoplasmic protein NCK2 | 223.0 | Evidence | |||||
| SRC | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 221.0 | Evidence | |||||
| SRC | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 209.0 | Evidence | |||||
| SRC | EPHB4 | EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor | 206.0 | Evidence | |||||
| SRC | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 206.0 | Evidence | |||||
| SRC | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 206.0 | Evidence |
|
||||
| SRC | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 181.0 | Evidence |
|
||||
| SRC | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 181.0 | Evidence | |||||
| SRC | SYK | SYK: Tyrosine-protein kinase SYK | 181.0 | Evidence |
|
||||
| SRC | CSK | CSK: Tyrosine-protein kinase CSK | 181.0 | Evidence |
|
||||
| SRC | LYN | LYN: Tyrosine-protein kinase Lyn | 181.0 | Evidence | |||||
| SRC | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 180.0 | Evidence |
|
||||
| SRC | HCK | N/A | 180.0 | Evidence | |||||
| SRC | KIT | KIT: Mast/stem cell growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 167.0 | Evidence |
|
||||
| SRC | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 167.0 | Evidence |
|
||||
| SRC | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 167.0 | Evidence | |||||
| SRC | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 156.0 | Evidence |
|
||||
| SRC | STAT3 | 156.0 | Evidence |
|
|||||
| SRC | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 147.0 | Evidence | |||||
| SRC | APS | SH2B2, APS: SH2B adapter protein 2 | 137.0 | Evidence | |||||
| SRC | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 137.0 | Evidence | |||||
| SRC | VAV1 | VAV1, VAV: Proto-oncogene vav | 137.0 | Evidence | |||||
| SRC | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 137.0 | Evidence |
|
||||
| SRC | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence |
|
||||
| SRC | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 135.0 | Evidence | |||||
| SRC | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 119.0 | Evidence | |||||
| SRC | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence |
|
||||
| SRC | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| SRC | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence |
|
||||
| SRC | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 117.0 | Evidence |
|
||||
| SRC | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 117.0 | Evidence | |||||
| SRC | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 109.0 | Evidence | |||||
| SRC | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 109.0 | Evidence | |||||
| SRC | INSR | INSR: Insulin receptor precursor | 101.0 | Evidence |
|
||||
| SRC | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 89.30 | Evidence |
|
||||
| SRC | JAK1 | 88.80 | Evidence | ||||||
| SRC | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 87.30 | Evidence | |||||
| SRC | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 82.10 | Evidence | |||||
| SRC | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 78.20 | Evidence | |||||
| SRC | EPHA4 | EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor | 76.90 | Evidence | |||||
| SRC | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 76.90 | Evidence |
|
||||
| SRC | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 66.50 | Evidence | |||||
| SRC | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 66.50 | Evidence |
|
||||
| SRC | GRB10 | N/A | 56.20 | Evidence |
|
||||
| SRC | GRAP | GRAP: GRB2-related adapter protein | 29.10 | Evidence | |||||
| SRC | DOK1 | DOK1: Docking protein 1 | 27.90 | Evidence |
|
||||
| SRC | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 26.40 | Evidence | |||||
| SRC | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 26.40 | Evidence |
|
||||
| SRC | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 23.50 | Evidence | |||||
| SRC | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 22.70 | Evidence | |||||
| SRC | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 22.70 | Evidence | |||||
| SRC | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 22.70 | Evidence |
|
||||
| SRC | WASPIP | N/A | 21.10 | Evidence | |||||
| SRC | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 19.70 | Evidence | |||||
| SRC | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 19.70 | Evidence |
|
||||
| SRC | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 17.30 | Evidence | |||||
| SRC | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 17.10 | Evidence | |||||
| SRC | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 15.10 | Evidence |
|
||||
| SRC | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.80 | Evidence |
|
||||
| SRC | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 13.80 | Evidence | |||||
| SRC | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 13.80 | Evidence | |||||
| SRC | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 11.20 | Evidence | |||||
| SRC | EFNB2 | EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor | 10.30 | Evidence |
|
||||
| SRC | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 9.89 | Evidence |
|
||||
| SRC | CTTN | CTTN, EMS1: Src substrate cortactin | 9.89 | Evidence |
|
||||
| SRC | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 9.89 | Evidence | |||||
| SRC | SOS1 | SOS1: Son of sevenless homolog 1 | 9.14 | Evidence | |||||
| SRC | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 7.59 | Evidence | |||||
| SRC | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 7.40 | Evidence | |||||
| SRC | EPOR | EPOR: Erythropoietin receptor precursor | 6.52 | Evidence | |||||
| SRC | EFNB1 | EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor | 6.13 | Evidence |
|
||||
| SRC | NRAS | NRAS, HRAS1: GTPase NRas precursor | 5.08 | Evidence | |||||
| SRC | IKBKE | IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit | 4.68 | Evidence | |||||
| SRC | SLC9A3 | SLC9A3, NHE3: Sodium/hydrogen exchanger 3 | 4.12 | Evidence | |||||
| SRC | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 3.57 | Evidence |
|
||||
| SRC | CAV1 | CAV1, CAV: Caveolin-1 | 3.49 | Evidence |
|
||||
| SRC | GIT2 | N/A | 3.34 | Evidence | |||||
| SRC | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 2.94 | Evidence | |||||
| SRC | FIGF | FIGF, VEGFD: Vascular endothelial growth factor D precursor | 2.65 | Evidence | |||||
| SRC | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 2.29 | Evidence |
|
||||
| SRC | RELA | RELA, NFKB3: Transcription factor p65 | 1.98 | Evidence | |||||
| SRC | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 1.72 | Evidence | |||||
| SRC | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 1.72 | Evidence | |||||
| SRC | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 1.72 | Evidence |
|
||||
| SRC | APC | N/A | 1.67 | Evidence | |||||
| SRC | B2M | B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro | 1.62 | Evidence | |||||
| SRC | CREBBP | CREBBP, CBP: CREB-binding protein | 1.57 | Evidence | |||||
| SRC | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 1.20 | Evidence | |||||
| SRC | EPHB6 | EPHB6: Ephrin type-B receptor 6 precursor | 1.13 | Evidence | |||||
| SRC | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
| SRC | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 1.13 | Evidence | |||||
| SRC | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
| SRC | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 1.13 | Evidence | |||||
| SRC | LNK | SH2B3, LNK: SH2B adapter protein 3 | 1.13 | Evidence | |||||
| SRC | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 1.04 | Evidence | |||||
| SRC | BMX | N/A | 1.04 | Evidence |
|
||||
| SRC | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 1.04 | Evidence | |||||
| SRC | RIN1 | RIN1: Ras and Rab interactor 1 | 1.04 | Evidence | |||||
| SRC | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 1.04 | Evidence | |||||
-